Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Drug Development and Industrial Pharmacy
|
January 12, 2019
Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo
Rezvan Yazdian-Robati, Atefeh Arab, Mohammad Ramezani, et al.
Immunology Letters
|
July 25, 2017
Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer
Nastaran Barati, Amin Reza Nikpoor, Atefeh Razazan, et al.
Journal of Drug Targeting
|
October 4, 2017
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
Atefeh Arab, Javad Behravan, Atefeh Razazan, et al.
Behavioural Brain Research
|
January 8, 2021
Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms through antioxidative effect and nitric oxide pathway in mice
Gholamreza Houshmand, Mehdi Pourasghar, Mohammadreza Shiran, et al.
Cancer Letters
|
March 28, 2018
Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
Nastaran Barati, Atefeh Razazan, Jessica Nicastro, et al.
Injury
|
April 5, 2025
Evaluation of topical vitamin k cream on repair of full thickness wound in diabetic rat
Adele Bahar, Ozra Akha, Sara Bayat, et al.
Immunologic Research
|
November 17, 2017
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8<sup>+</sup> T response
Atefeh Arab, Jessica Nicastro, Roderick Slavcev, et al.
Plos One
|
October 19, 2017
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
Atefeh Razazan, Javad Behravan, Atefeh Arab, et al.
Journal of Cellular Biochemistry
|
November 1, 2018
Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer
Saeedeh Rastakhiz, Mona Yazdani, Sheida Shariat, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
March 5, 2019
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
Niloofar Farzad, Nastaran Barati, Amir Abbas Momtazi-Borojeni, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Drug Development and Industrial Pharmacy
|
January 12, 2019
Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo
Rezvan Yazdian-Robati, Atefeh Arab, Mohammad Ramezani, et al.
Immunology Letters
|
July 25, 2017
Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer
Nastaran Barati, Amin Reza Nikpoor, Atefeh Razazan, et al.
Journal of Drug Targeting
|
October 4, 2017
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
Atefeh Arab, Javad Behravan, Atefeh Razazan, et al.
Behavioural Brain Research
|
January 8, 2021
Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms through antioxidative effect and nitric oxide pathway in mice
Gholamreza Houshmand, Mehdi Pourasghar, Mohammadreza Shiran, et al.
Cancer Letters
|
March 28, 2018
Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
Nastaran Barati, Atefeh Razazan, Jessica Nicastro, et al.
Injury
|
April 5, 2025
Evaluation of topical vitamin k cream on repair of full thickness wound in diabetic rat
Adele Bahar, Ozra Akha, Sara Bayat, et al.
Immunologic Research
|
November 17, 2017
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8<sup>+</sup> T response
Atefeh Arab, Jessica Nicastro, Roderick Slavcev, et al.
Plos One
|
October 19, 2017
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
Atefeh Razazan, Javad Behravan, Atefeh Arab, et al.
Journal of Cellular Biochemistry
|
November 1, 2018
Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer
Saeedeh Rastakhiz, Mona Yazdani, Sheida Shariat, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
March 5, 2019
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
Niloofar Farzad, Nastaran Barati, Amir Abbas Momtazi-Borojeni, et al.
Page
of 3